Holen Sie sich die Stockscreener-App
44.92
0.76%
-0.3309
Schlusskurs vom Vortag:
$45.25
Offen:
$45.53
24-Stunden-Volumen:
1.04M
Relative Volume:
0.41
Marktkapitalisierung:
$4.58B
Einnahmen:
$47.30M
Nettoeinkommen (Verlust:
$-225.97M
KGV:
-19.11
EPS:
-2.35
Netto-Cashflow:
$-188.86M
1W Leistung:
+9.31%
1M Leistung:
+55.11%
6M Leistung:
+31.80%
1J Leistung:
-1.27%
1-Tages-Spanne:
$44.67
$46.25
1-Wochen-Bereich:
$41.00
$46.32
52-Wochen-Spanne:
$22.71
$46.98
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Firmenname
Scholar Rock Holding Corp
Sektor
Branche
Telefon
857-259-3860
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie SRRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
44.92 | 4.62B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.92 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.15 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.13 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.47 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.88 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wolfe Research | Outperform |
| 2025-10-09 | Eingeleitet | BofA Securities | Buy |
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-09-15 | Eingeleitet | Leerink Partners | Outperform |
| 2025-08-21 | Fortgesetzt | Jefferies | Buy |
| 2025-07-30 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-07-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-26 | Bestätigt | H.C. Wainwright | Buy |
| 2024-10-07 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-28 | Eingeleitet | Raymond James | Strong Buy |
| 2023-10-25 | Hochstufung | Jefferies | Hold → Buy |
| 2023-04-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-07-12 | Eingeleitet | Truist | Buy |
| 2022-03-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-22 | Herabstufung | Jefferies | Buy → Hold |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-06 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-12 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
Hood River Capital Management LLC Acquires 30,806 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Kennedy Capital Management LLC Has $1.93 Million Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Norges Bank Makes New $41.63 Million Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 136,462 Shares of Stock - MarketBeat
Russell Investments Group Ltd. Lowers Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
Franklin Resources Inc. Increases Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Insider Sold Shares Worth $6,169,788, According to a Recent SEC Filing - marketscreener.com
Scholar Rock Holding Corp's Chief Scientific Officer Sells Shares - TradingView
FDA Warning Letter And Backup Plant Plans Could Be A Game Changer For Scholar Rock (SRRK) - Yahoo Finance
Scholar Rock (SRRK) Valuation Revisited After FDA Warning Letter to Key Manufacturing Partner - simplywall.st
Scholar Rock (SRRK) valuation after FDA manufacturing update and apitegromab resubmission plans - Yahoo Finance
Scholar Rock (NASDAQ:SRRK) Trading Up 7.8%Still a Buy? - MarketBeat
Scholar Rock Holding Corporation $SRRK Position Cut by Fisher Asset Management LLC - MarketBeat
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away - AOL.com
Scholar Rock (NASDAQ:SRRK) Shares Gap DownShould You Sell? - MarketBeat
FDA Manufacturing Letter And Backup Plant Plans Could Be A Game Changer For Scholar Rock (SRRK) - simplywall.st
Can Scholar Rock Holding Corporation stock deliver strong Q4 earningsWeekly Market Outlook & Low Risk High Win Rate Stock Picks - Newser
Scholar Rock updates on Catalent Indiana FDA warning letter and apitegromab timeline - Investing.com Nigeria
Scholar Rock Faces FDA Warning, Plans 2026 Launch - TipRanks
Scholar Rock Updates on FDA Warning and Apitegromab Launch Plans - TradingView
Scholar Rock Holding (SRRK) Stock Analysis Report | Financials & Insights - Benzinga
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating - 富途牛牛
Inceptionr LLC Invests $205,000 in Scholar Rock Holding Corporation $SRRK - MarketBeat
Loomis Sayles & Co. L P Sells 17,706 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation $SRRK Shares Bought by American Century Companies Inc. - MarketBeat
Aisling Capital Management LP's Scholar Rock Holding Corp(SRRK) Holding History - GuruFocus
FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults - Benzinga
Universal Beteiligungs und Servicegesellschaft mbH Grows Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat
Intech Investment Management LLC Lowers Stock Holdings in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation $SRRK Shares Bought by Geode Capital Management LLC - MarketBeat
Scholar Rock Holding (SRRK): A Fresh Look at Valuation Following Recent Biotech Sector Moves - Sahm
Ensign Peak Advisors Inc Purchases 264,693 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
After tax other income/expense of Scholar Rock Holding Corp. – HAM:2QK - TradingView
Scholar Rock (NASDAQ:SRRK) Stock Rating Upgraded by Wolfe Research - MarketBeat
Eagle Health Investments LP Makes New $9.54 Million Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding CorporationCommon Stock (NQ: SRRK - Markets Financial Content
Cantor Fitzgerald Lowers Earnings Estimates for Scholar Rock - MarketBeat
Will Scholar Rock Holding Corporation (2QK) stock maintain strong growthJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Why Scholar Rock Holding Corporation (2QK) stock appears on watchlistsTrade Risk Summary & Short-Term High Return Ideas - newser.com
Using data filters to optimize entry into Scholar Rock Holding CorporationPortfolio Risk Report & Smart Swing Trading Alerts - newser.com
Using economic indicators to assess Scholar Rock Holding Corporation potential2025 Volatility Report & Smart Money Movement Alerts - newser.com
Will Scholar Rock Holding Corporation (2QK) stock attract long term capital inflowsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
JPMorgan Chase & Co. Boosts Scholar Rock (NASDAQ:SRRK) Price Target to $47.00 - MarketBeat
Scholar Rock (NASDAQ:SRRK) Shares Up 4.6% Following Analyst Upgrade - MarketBeat
Scholar Rock (NASDAQ:SRRK) Earns Outperform Rating from Analysts at Wolfe Research - MarketBeat
Published on: 2025-11-19 06:08:10 - newser.com
Wolfe Research Initiates Coverage of Scholar Rock Holding (SRRK) with Outperform Recommendation - Nasdaq
Scholar Rock Holding buy JPMorgan Chase & Co. - sharewise.com
Scholar Rock at Jefferies: Navigating FDA Challenges By Investing.com - Investing.com India
Scholar Rock at Jefferies: Navigating FDA Challenges - Investing.com
Scholar Rock Holding (SRRK): Wolfe Research Initiates Coverage w - GuruFocus
Finanzdaten der Scholar Rock Holding Corp-Aktie (SRRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):